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Abstract
Interleukin 22 (IL-22) is a T-cell secreted cytokine that modulates inflammatory response in nonhematopoietic tissues such
as epithelium and liver. The function of IL-22 in adipose tissue is currently unknown. We generated a transgenic mouse
model with overexpression of IL-22 specifically in adipose tissue. The IL-22 transgenic mice had no apparent changes in
obesity and insulin resistance after feeding with high fat diet (HFD). Unexpectedly, all the IL-22 transgenic mice fed with
HFD for four months developed spontaneous tumors in epididymal adipose tissue. Histological analysis indicated that the
tumors were well-differentiated liposarcomas with infiltration of inflammatory cells. IL-22 overexpression promotes
production of inflammatory cytokines such as IL-1b and IL-10 and stimulates ERK phosphorylation in adipose tissue.
Furthermore, IL-22 treatment in differentiated 3T3-L1 adipocytes could induce IL-1b and IL-10 expression, together with
stimulation of ERK phosphorylation. Taken together, our study not only established a novel mouse model with spontaneous
liposarcoma, but also revealed that IL-22 overexpression may collaborate with diet-induced obesity to impact on tumor
development in mouse.
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Introduction
Interleukin (IL)-22 is a T cell secreted and IL-10-related
cytokine that was first identified in 2000 [1,2]. IL-22 exerts its
biological activities on tissues such as skin, liver, kidney, respiratory
and digestive systems, but not on cells of hematopoietic lineage.
The effect of IL-22 as a cytokine is dependent on the location of its
action as well as the local cytokine milieu [3,4]. For instance, IL-22
can exert either pro-inflammatory or anti-inflammatory effect
dependent on cellular context [3,4]. IL-22 has a pro-inflammatory
effect in a mouse model of psoriasis-like skin inflammation [5]. It
also has a pro-inflammatory effect in promoting bacterial load and
organ failure during septic peritonitis [6]. On the other hand, IL-
22 has an anti-inflammatory effect to ameliorate local intestinal
inflammation in a mouse model of ulcerative colitis [7]. A fusion
gene between IL-22 and Ig ameliorates experimental autoimmune
myocarditis in rats [8]. IL-22 also has an in vivo protective function
in mice against concanavalin A-, carbon tetrachloride-, and Fas
ligand-induced hepatic injury, necrosis and apoptosis [9]. In
addition, IL-22 has a protective function in alcohol-induced liver
injury [10], as well as T cell-mediated hepatitis in the mouse [11].
Consistently, overexpression of IL-22 in mouse liver can
ameliorate concanavalin A-induced T cell hepatitis [12].
In addition to its primary role in modulation of inflammation,
IL-22 contributes to tumor cell growth and apoptosis. It was
reported that IL-22 can promote cell growth and survival in
HepG2 cells by activating STAT3 and inducing expression of a
variety of anti-apoptotic and mitogenic proteins [11]. In non-small
cell lung carcinoma (NSCLC), overexpression of IL-22 protected
lung cancer cell lines from apoptosis, while downregulation of IL-
22 significantly inhibited the human tumor cell growth in BALB/c
nude mice [13]. In contrast, in breast cancer cells, IL-22 was found
to effectively reduce the growth of tumor cells, correlated with an
inhibition on ERK and AKT phosphorylation and induction of
cell cycle arrest [14]. Therefore, the effect of IL-22 on cancer
development appears to be dependent on cellular context.
Our group recently found that IL-22 play a protective role in
high fat diet induced liver steatosis through down-regulating the
expression of lipogenesis-related genes including critical transcrip-
tion factors and enzymes for lipid synthesis [15]. In this study, we
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tissue by generation of a transgenic mouse model with adipose-
specific expression of IL-22. Interestingly, the mice with
overexpression of IL-22 in adipose tissue had neither apparent
phenotype nor metabolic alteration when fed with high fat diet.
However, the IL-22 transgenic mice developed spontaneous
liposarcomas in adipose tissue after long-term feeding with high
fat diet, indicating that diet may interact with inflammation
changes associated with IL-22 overexpression in tumorigenesis in
adipose tissue.
Materials and Methods
Generation of IL-22 transgenic mouse
All animals were kept and used under the guidelines of the
Institutional Animal Care and Use Committee of the Institute for
Nutritional Sciences, Chinese Academy of Sciences (CAS), with
free access to standard mouse chow and tap water. All of the
experimental procedures were carried out in accordance with the
CAS ethics commission with an approval number 2010-AN-8.
The full length mouse IL-22 cDNA was amplified by RT-PCR
with mouse thymus cDNA. After confirmation by DNA
sequencing, the mouse cDNA was cloned into pBS-aP2-sv40pA
vector (from Addgene, Cambridge, MA, USA). To generate
transgenic mice, the transgenic cassette was excised from the
plasmid and used in microinjection into the pronuclei of fertilized
oocytes of the ICR strain of mice. The transgenic mice were
genotyped by PCR with genomic DNA with primers 59-
AAACATACAGGGTCTGGTCAT-39 and 59-GCATAAAGG-
TGCGGTTGA -39. All the mice used in this study were of ICR
background.
Genomic DNA extraction, RNA isolation, reverse
transcription and PCR (RT-PCR), and quantitative
real-time RT-PCR (qRT-PCR)
Genomic DNA was extracted from mouse tail with heating at
100uC for at least 1 hour in 50 mM NaOH, followed by addition
of Tris-Cl solution (pH 8.0). Total RNA was extracted from tissues
of the mice or cells using Trizol reagent (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s protocol. Reverse tran-
scription-PCR (RT-PCR) was performed as previously described
[15]. The primers for RT-PCR were as follows: 59-GTG-
GGATCCCTGATGGCTGTCCTGCAG-39 and 59-AGCGAA-
TTCTCGCTCAGACTGCAAGCAT-39 for mouse IL-22, 59-
ATGAAGACACTACTGACCATCCT-39 and 59- CAGCCAC-
TTTCTCTCTCCGT -39 for mouse IL-22R1, 59- AGGGCT-
GAATTTGCAGATGA -39 and 59- CCGTTTTTCCAGTAT-
TGCAC-39 for mouse IL-10R2, 59-CAACGGCACAGTCA-
AGG-39 and 59-AAGTCGCAGGAGACAACC-39 for mouse
GAPDH. The expression levels of IL-22, IL-1b, IL-10, and
IFN-c were determined by qRT-PCR using SYBR Green real-
time PCR master mix (TOYOBO, Osaka, Japan) with 7900 real-
time instrument (Applied Biosystems, Carlsbad, CA, USA). The
primers used are as follows for qRT-PCR: 59-CATGCAG-
GAGGTGGTACCTT -39 and 59-CAGACGCAAGCATTTCT-
CAG-39 for mouse IL-22, 59-AAAAAAGCCTCGTGCTGTCG-
39 and 59-GTCGTTGCTTGGTTCTCCTTG -39 for mouse IL-
1b,5 9- ACTGCACCCACTTCCCAGT-39 and 59-TTGTCC-
AGCTGGTCCTTTGT-39 for mouse IL-10, 59-TAGCCAAGA-
CTGTGATTGCGG-39 and 59-AGACATCTCCTCCCATCA-
GCAG-39 for mouse IFN-c,5 9- TCCATCCAGTTGCCTT-
CTTG-39 and 59-TTCCACGATTTCCCAGAGAAC-39 for
mouse IL-6, 59-AAGCCTGTAGCCCACGTCGTA-39 and 59-
AGGTACAACCCATCGGCTGG -39 for mouse TNF-a,5 9-GA-
TCATTGCTCCTCCTGAGC-39 and 59-ACTCCTGCTTGC-
TGATCCAC-39 for b-actin used to normalize qRT-PCR.
Analysis of food intake, glucose tolerance test (GTT), and
insulin tolerance test (ITT)
The male wild type and IL-22 transgenic male mice of 1 month
old were fed with either normal chow (SLACOM, Shanghai,
China) or high fat diet (containing 60% calories from fat, from
Research Diets Inc. New Brunswick, NJ, USA). Food intake was
recorded every two days. For GTT and ITT, the mice were fasted
overnight, followed by intraperitoneal injection of glucose (1 g/kg
body weight, for GTT) or insulin (1 U/kg body weight, for ITT)
respectively. Blood glucose levels at various times after the
injection were determined by an electronic glucometer (Freestyle
Freedom, Abbott Diabetes Care, Alameda, CA, USA).
Hematoxylin-eosin staining and immunohistochemistry
Fresh epididymal white adipose tissue (eWAT) and tumors were
fixed in 10% formalin/phosphate-buffered saline, and then
embedded with paraffin. Sections were subjected to standard
hematoxylin-eosin (HE) staining and immunohistochemistry as
previously described [16].
3T3-L1 cell culture, differentiation, IL-22 treatment, and
immunoblotting
3T3-L1 mouse fibroblast cells were obtained from the Bank/
Stem Cell Bank, Shanghai Institute for Biological Sciences,
Chinese Academy of Sciences. The cells were grown under 5%
CO2 in standard medium containing Dulbecco’s Modified Eagles
Medium (GIBCO,Carlsbad, CA, USA), 10% fetal bovine serum
(FBS) and 0.1% penicillin-streptomycin mixture (GIBCO). For
adipocyte differentiation, 3T3-L1 cells were allowed to reach
confluence and at two days post confluence (day 0), the cells were
induced to differentiate under 10% CO2 environments with a
medium containing 10% fetal bovine serum, 10 mg/ml insulin,
1 mM dexamethasone, and 0.5 mM IBMX for 2 days. Thereafter,
post-differentiation medium containing only insulin and 10% FBS
was added and the cells were cultured for 2 more days. From then
on the culture medium was replenished every 2 days with standard
medium. Fully differentiated 3T3-L1 cells were treated for
48 hours with 500 ng/ml recombinant IL-22 as described
previously [15]. The IL-22-treated cells were then used for RT-
PCR and immunoblotting as previously described [15]. Phospho-
ERK1/2 antibody was purchased from Cell Signaling Technology
(Danvers, MA, USA). Total ERK1/2 antibody was from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). The antibody for
tubulin was from Sigma-Aldrich (St. Louis, MO, USA).
Measurement of serum IL-22 concentration
The protein concentration of mouse serum IL-22 was measured
by an ELISA kit from eBioscience (San Diego, CA, USA)
following manufacturer’s instruction.
Statistical analysis
All the data were analyzed by unpaired two-tailed Student’s
t-test and expressed as means 6 standard deviation.
Results
Generation and characterization of transgenic mice with
IL-22 expression in adipose tissues
Our previous study has indicated that IL-22 has an effect on
lipogenesis in the liver [15]. We therefore speculated that IL-22
IL-22 and Liposarcoma
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interacting with two membrane receptors, a specific receptor IL-
22R1 and a common component IL-10R2 [17]. We analyzed
whether adipose tissues express these two receptors. Different
mouse tissues were used to isolate total RNA, followed by analysis
with RT-PCR (Figure 1A). We found that both of the IL-22
receptors were present in many mouse tissues including epididy-
mal white adipose tissue (eWAT) and brown fat tissue (BAT),
indicating that IL-22 may play a functional role in these tissues.
To further analyze the potential function of IL-22 on adipose
tissues, we generated a transgenic mouse model with IL-22
overexpression in adipocytes. The full-length mouse IL-22 cDNA
was cloned downstream of aP2 promoter that specifies gene
expression only in adipocytes (Figure 1B). The transgenic cassette
was microinjected into the pronuclei of fertilized ICR mouse eggs to
generate IL-22 transgenic (IL-22-TG) mice. IL-22-TG mice were
then crossed with ICR mice to generate offspring used in the study.
In wild type mice, IL-22 mRNA was mainly present in the thymus
(Figure 1C). However, in IL-22-TG mice, IL-22 was highly
expressed in eWAT and BAT (Figure 1C), confirming a successful
overexpression of IL-22 in adipose tissues under aP2 promoter in
the transgenic mice. We further analyzed the expression of IL-22 in
eWAT using real-time quantitative RT-PCR method. We found
that the IL-22 mRNA level in IL-22-TG mice was markedly
elevated in comparison with the wild type animals (Figure 1D).
However, the blood IL-22 protein level appeared not significantly
affected by IL-22 overexpression in the adipose tissues.
IL-22 overexpression in adipose tissue has no apparent
effect on metabolism
As adipose tissue is one of the major organs involved in the
regulation of metabolism, we investigated the potential effect of IL-
22 overexpression inadipose tissue on obesity and insulin resistance.
The wild type and IL-22-TGmalemicewerefed with eithernormal
chow (NC) or high fat diet (HFD) starting from age of 1-month. We
analyzed their metabolic features after feeding with NC or HFD for
4 months. We found that HFD could increase the body weight in
both wild type and IL-22-TG mice, but there was no significant
difference in body weight between the two groups of mice under
either NC or HFD (Figure 2A). The food intake was also not
changed between the wild type and IL-22-TG mice fed with HFD
for 4 months (Figure 2B). In addition, while HFD could elevate the
weight of epididymal WAT, there was no significant difference
between the two groups of mice (Figure 2C), indicating that IL-22
overexpression in adipose tissue has no significant effect on HFD-
induced obesity. We next analyzed the potential effect of IL-22
overexpression in adipose tissue on glucose metabolism. By glucose
tolerance test (GTT) and insulin tolerance test (ITT), we did not
detect a significant difference between the two groups of mice fed
after feeding with HFD (Figure 2D and 2E). Collectively, these data
indicate that IL-22 overexpression has no apparent effect on HFD-
induced obesity and insulin resistance in vivo.
High fat diet induced formation of spontaneous
liposarcomas in IL-22-TG mice
Unexpectedly, we found that long-term HFD feeding was able
to induce formation of spontaneous tumors in adipose tissue. Both
wild type and IL-22-TG mice were fed with either normal chow or
HFD for 4 months. Surprisingly, 100% of IL-22-TG mice fed with
HFD developed spontaneous tumors in epididymal adipose tissue
(Figure 3A). However, none of the wild type mice fed with HFD or
IL-22-TG mice fed with normal chow had tumors in adipose tissue
(Figure 3A). All the tumors formed in the mice were within
epididymis with most of them having necrosis in the middle
(Figure 3B). We did not observe metastasis of the tumor to other
organs in the mice (data not shown).
Figure 1. Generation of transgenic mice with IL-22 specifically
expressed in adipose tissue. (A) IL-22 receptors are present in
adipose tissues. Various tissues were isolated from ICR mice and used in
RT-PCR to detect the expression levels of IL-22R1 and IL-10R2. GAPDH
was used as a loading control. eWAT stands for epididymal white fat
and BAT for brown fat. (B) A diagram to depict the transgenic construct.
The full length mouse IL-22 cDNA was cloned downstream of aP2
promoter. (C) Analysis of IL-22 mRNA levels in wild type and IL-22
transgenic (IL-22-TG) mice. Various mouse tissues were used in RT-PCR
to detect mRNA level of IL-22. Note that in comparison with wild type
control, IL-22 expression was markedly increased in eWAT and BAT in IL-
22-TG mice. (D) Analysis of IL-22 level of mouse eWAT by real-time
quantitative RT-PCR (qRT-PCR). The relative expression level of IL-22
compared with b-actin was shown as mean 6 SD (n=7 for each group).
* indicates p,0.05 between the two groups. (E) Measurement of serum
IL-22 protein levels. The sera of both wild type and IL-22-TG mice were
used to determine the IL-22 protein level. The data are shown as mean
6 SD (n=7 for each group).
doi:10.1371/journal.pone.0023737.g001
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type and IL-22-TG mice fed with either normal chow (NC) or high fat diet (HFD) for 4 months (n=7 and 8 for the two groups respectively). (D, E)
Glucose tolerance test (D) and insulin tolerance test (E) were performed with wild-type and IL-22-TG mice after fed with HFD for 4 months (n=7 and 8
for the two groups respectively).
doi:10.1371/journal.pone.0023737.g002
Figure 3. High fat diet induced spontaneous tumors in adipose tissue in IL-22-TG mice. (A) Summary of spontaneous tumor incidence in
epididymal adipose tissue in mice fed with normal chow (NC) or high fat diet (HFD) for various length of time. HFD was started in the mice at 1-
month-age. Note that spontaneous tumor formation in 100% of IL-22-TG mice after feeding with HFD for 4 months. (B) Representative pictures of
epididymis of the wild type and IL-22-TG mice. The arrow indicates spontaneous tumors formed in the IL-22-TG mice fed with HFD for 4 months.
doi:10.1371/journal.pone.0023737.g003
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revealed that the adipose tissue adjacent to the tumor were similar
to that of wild type (Figure 4A). However, the shape of the
adipocytes in IL-22-TG mice was not as regular as that of
adipocytes in wild type mice (Figure 4A). HE staining with the
tumor samples revealed that these tumors were most likely
liposarcomas of the well-differentiated type (Figure 4B). Microscop-
ically, the tumor was composed of broad sheets and streaks of
adipocytes admixed with occasional lipoblasts, separated by fibrous
septa containing spindle cells with hyperchromatic and mildly
pleomorphic nuclei. Signet-ring cells resembling normal adipose
tissue and multivacuolar lipoblastswere also seen. The size of the fat
cells was variable and some lesions within the tumor were infiltrated
by a small to moderate numberof chronic inflammatorycells.Large
nuclei and minor atypia of the cells werealsoobserved. Therefore, a
diagnosis ofwell-differentiated‘‘lipoma-like’’liposarcoma wasmade
basedonthehistopathologicalappearanceofthetumors(Figure4B).
IL-22 promotes production of inflammatory cytokines
and ERK phosphorylation in adipose tissue and
adipocytes
It has been proposed that inflammation contributes to
tumorigenesis [18], and IL-22 has a functional role in modulating
inflammatory response in peripheral tissues [3,4]. We hypothe-
sized that IL-22-mediated inflammatory response might, at least
partially, contribute to the development of the tumors in adipose
Figure 4. Histological and histochemical analyses of the liposarcoma in IL-22-TG mice fed with high fat diet. (A) HE staining of
epididymal adipose tissue in wild type mouse and tumor adjacent tissue in IL-22-TG mouse. (B) HE staining of liposarcoma samples in IL-22-TG mice.
The pictures in the right panel are amplified images of the inset inside the pictures in left panel (marked by blue solid line).
doi:10.1371/journal.pone.0023737.g004
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overexpression on the expression of a set of inflammation-related
cytokines in adipose tissue. Interestingly, we found that the mRNA
levels of IL-1b and IL-10 were significantly elevated by IL-22
overexpression in adipose tissue (Figure 5A). The mRNA level of
INF-c was not significantly altered by IL-22 overexpression
(Figure 5A). Furthermore, the mRNA levels of TNF-a and IL-6
were also significantly elevated by IL-22 overexpression
(Figure 5A). These data indicate that IL-22 overexpression might
induce expression of a subset of inflammatory cytokines in adipose
tissue, likely contributing to the development of spontaneous
liposarcomas in the mouse upon HFD feeding.
In addition, we analyzed the level of phosphorylated ERK to
evaluate the activation status of Ras to ERK signaling pathway, a
primary cascade involved in cell proliferation [19]. We found that
phosphorylated ERK level was markedly elevated in the tumors of
IL-22-TG mice (Figure 5B), indicating that Ras to ERK signaling
pathway might be also implicated in the formation of spontaneous
liposarcomas in IL-22-TG mice.
We next used a cell model to further analyze the function of IL-
22 on inflammation and ERK activation in adipocytes. 3T3-L1
preadipocytes were induced to mature adipocytes using the
classical ‘‘cocktail’’ differentiation protocol. IL-22 receptors IL-
22R1 and IL-10R2 were both present in differentiated 3T3-L1
adipocytes (Figure 6A), indicating that these cells are likely
responsive to IL-22. Interestingly, treatment of the cells appeared
to increase the expression of IL-22R1 (Figure 6A). Similar to the
findings in mouse adipose tissue (Figure 5A), IL-22 treatment was
able to significantly elevate expression of IL-1b and IL-10 in
differentiated 3T3-L1 adipocytes (Figure 6B). However, IL-22 had
no effect on the expression of INF-c, TNF-a and IL-6 (Figure 6B).
Furthermore, IL-22 could stimulate ERK phosphorylation in a
time-dependent manner (Figure 6C). Collectively, these findings
indicate that IL-22-induced expression of inflammatory cytokines
and activation of ERK may contribute to the formation of
spontaneous liposarcomas in IL-22-TG mice fed with HFD.
Discussion
In this study, we analyzed the potential function of IL-22 in
adipose tissue. Overexpression of IL-22 in adipose tissue had no
apparent effect on the development of obesity and changes of
glucose homeostasis induced by high fat diet. However, high fat
diet together with IL-22 overexpression could induce formation of
spontaneous liposarcomas in adipose tissue with 100% penetrance.
IL-22 could also induce expression of a subset of inflammatory
cytokines including IL-1b and IL-10 in both adipose tissue and
adipocytes. Furthermore, IL-22 could elevate the activation of
Figure 5. IL-22 promotes cytokine production and ERK phosphorylation in adipose tissue. (A) The mRNA levels of a set of inflammatory
cytokines were increased in IL-22-TG mice. Epididymal white fat tissues were isolated from wild type and IL-22-TG mice (male, at 4 months old) and
used in real-time quantitative RT-PCR to detect the expression levels of IL-1b, IL-10, INF-c, TNF-a, and IL-6. The data are shown as mean 6 SD (n=7 for
each group). * indicates p,0.05 and ** for p,0.01 between the two mouse groups. (B) Immunohistochemistry of liposarcoma and tumor-adjacent
tissues to detect the level of phosphorylated ERK.
doi:10.1371/journal.pone.0023737.g005
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reveals for the first time that high fat diet can functionally interact
with IL-22 overexpression to promote formation of spontaneous
tumors in adipose tissue.
Intriguingly, high fat diet is a premise for the development of
spontaneous liposarcomas in IL-22-TG mice. None of IL-22-TG
mice fed with normal chow could form adipose tumors. This
observation is consistent with the idea that nutritional cues are one
of the major factors contributing to cancer formation [20]. It was
proposed that the majority of cancers are caused by lifestyle and
environmental factors, rather than gene mutations [20]. Among
elements contributing to tumorigenesis, up to 35% were due to
diet, and 14% to 20% were related to obesity [21]. The link
between obesity and carcinogenesis is likely caused by an elevated
level of chronic low-level inflammation in obesity [22]. Interest-
ingly, it has been found that inflammation contributes to
tumorigenesis [18], and that an inflammatory microenvironment
is an essential component of all tumors [23]. Lately, it was found
that dietary obesity was able to promote inflammation and
tumorigenesis in the liver [24]. We propose here that the
inflammatory responses induced by both IL-22 overexpression
and obesity could jointly contribute to the development of
spontaneous liposarcomas in the mouse, although the underlying
molecular mechanism still awaits detailed characterization in the
future.
Our study established a new liposarcoma mouse model that
may facilitate liposarcoma research in the future. Currently there
are very few mouse models of liposarcoma. Overexpression of the
Fus-Chop fusion protein in primary mesenchymal progenitor cells
is able to induce formation of myxoid liposarcoma [25].
Furthermore, the Fus-Chop fusion protein could combine with
p53 deficiency to induce liposarcoma in mouse adipose-derived
mesenchymal stem/stromal cells [26]. Among liposarcomas in
humans, well-differentiated (WDLPS) tumors account for about
40–45% of all liposarcomas and represent the largest subgroup of
adipocytic neoplasm [27]. According to the morphological and
histological characteristics of liposarcoma in our model, the tumors
appear to be the well-differentiated ‘‘lipoma-like’’ liposarcomas. In
addition, we analyzed the mRNA level of MDM2 gene, a key
feature of well-differentiated liposarcoma, and found that MDM2
expression was markedly elevated in the adipose tumors in IL-22-
TG mice fed with HFD (data not shown). Furthermore, we found
no metastasis of the tumor in these mice. These features are
consistent with the findings of WDLPS in humans [28,29].
Interestingly, both obesity and IL-22, two factors required for
liposarcoma formation in the mouse, are associated with
inflammatory response. We therefore propose that the altered
inflammatory status by both obesity and IL-22 overexpression
contribute to WDLPS tumor formation in the mouse. Consistent
with this hypothesis, we did found that IL-22 is able to upregulated
mRNA level of IL-1b and IL-10 in adipose tissue and adipocytes.
IL-1b is a well studied cytokine with a potent pro-inflammatory
effect [30]. Although IL-10 is considered to an anti-inflammatory
cytokine [31], IL-10 can function as a growth factor to promote
melanoma cell proliferation or possess an anti-apoptotic effect in
lung cancer cells [32,33]. In addition, we observed an increased
level of ERK phosphorylation both in mouse liposarcoma samples
and IL-22-treated adipocytes. This observation is consistent with
the finding that IL-22 is able to activate ERK signaling pathway in
other cell type [34,35]. Among the MAPK signaling cascades
implicated in tumorigenesis, ERK signaling pathway plays a vital
role in protooncogene transcription and tumor cell growth [19].
Therefore, it is likely that IL-22-induced activation of ERK
signaling pathway, together with the alteration of local inflamma-
tory microenvironment impacted by both IL-22 and diet-induced
obesity, may contribute to the development of spontaneous
liposarcoma in the IL-22 transgenic mouse.
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